Cite Filings / XLO
Feed Companies Filings Check
Sign in

CIK 0001840233

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851623397
Phone
+1 617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
Filings Financials Insiders Search text
All 364 Financials 90 Shareholder Meetings 10 Executive Compensation 79 Insider Trading 150 Beneficial Ownership Interest 58 Business Combinations 66 Public Offerings 31 Mutual Funds and ETFs 7 Others 32
›
Filed in
  1. No filings match these filters. Clear filters
  2. 424B4 Offering Prospectus 2021-10-22
  3. S-1/A Offering Registration Statement 2021-10-20
  4. CORRESP Other Correspondence Between Filers and SEC Staff 2021-10-19
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2021-10-19
  6. CORRESP Other Correspondence Between Filers and SEC Staff 2021-10-18
  7. S-1/A Offering Registration Statement 2021-10-18
  8. UPLOAD Other SEC-generated Letter 2021-10-13
  9. CORRESP Other Correspondence Between Filers and SEC Staff 2021-10-01
  10. S-1 Offering Registration Statement 2021-10-01
  11. UPLOAD Other SEC-generated Letter 2021-09-23
  12. UPLOAD Other SEC-generated Letter 2021-06-21

Page 2 of 2 · 31 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…